ダウンロード数: 176
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
33_1180.pdf | 372.31 kB | Adobe PDF | 見る/開く |
タイトル: | 表在性膀胱腫瘍に対するAclacinomycin-AとCystosine Arabinosideの併用による膀胱内注入療法の経験 |
その他のタイトル: | Our experience with combined intravesical instillation therapy of superficial bladder tumor using Aclacinomycin-A (ACM) and cytosine arabinoside (CA) |
著者: | 津ケ谷, 正行 岩瀬, 豊 阪上, 洋 和志田, 裕人 |
著者名の別形: | TSUGAYA, Masayuki IWASE, Yutaka SAKAGAMI, Hiroshi WASHIDA, Hiroto |
キーワード: | Bladder tumor Aclacinomycin-A (ACM) Cytocine arabinoside (CA) Intravesical instillation |
発行日: | Aug-1987 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 33 |
号: | 8 |
開始ページ: | 1180 |
終了ページ: | 1184 |
抄録: | Thirteen patients with recurrent superficial bladder tumors were treated by combined intravesical instillation of Aclacinomycin-A (ACM) and cytosine arabinoside (CA). Prophylactic effects of this combined instillation therapy were studied in 7 patients. A solution of 200 micrograms/ml of ACM and 600 micrograms/ml of CA was instilled into the bladder. The instillation aimed for treatment was carried out once a week until ten treatments had been given. Complete response was attained in 2 patients and partial response in 3 patients, but tumor size increased by more than 50% in 6 of the 13 patients. No change was observed in the remaining 2 patients. Recurrence of the tumors was observed in 3 of the 7 patients who were treated by this prophylactic combined instillation therapy. Local side effects such as bladder irritability were found in 2 of the 20 patients. No systemic side effects were noted in any patients. Although the side effects were reduced, we were not satisfied with the results of this therapy. |
URI: | http://hdl.handle.net/2433/119241 |
PubMed ID: | 3480687 |
出現コレクション: | Vol.33 No.8 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。